Drug Shortages reported to us

Drug Shortages can occur because of manufacturing and quality problems, delays and discontinuations.

Sort By: Date | Name

Wednesday, September 16, 2026

FDA Melphalan Hydrochloride Injection (NDC 63323076020) FRESENIUS KABI USA
FDA Mesalamine Capsule Extended Release (NDC 54092018981) TAKEDA PHARMACEUTICALS AMERICA
FDA Mesalamine Capsule Extended Release (NDC 54092019112) TAKEDA PHARMACEUTICALS AMERICA

Friday, September 11, 2026

FDA Cisatracurium Besylate Injection (NDC 00409109802) HOSPIRA
FDA Micafungin Sodium Injection (NDC 42023023010) ENDO USA
FDA Micafungin Sodium Injection (NDC 42023022910) ENDO USA

Wednesday, September 9, 2026

FDA Imipenem Anhydrous Cilastatin and Relebactam Anhydrous Injec (NDC 00006385602) MERCK SHARP & DOHME

Tuesday, September 1, 2026

FDA Glycerol Phenylbutyrate Oral Liquid (NDC 75987005006) HORIZON THERAPEUTICS USA
FDA Insulin Glargine-aglr Injection (NDC 00002898005) LILLY
FDA Insulin Lispro Injection (NDC 00002775205) LILLY
FDA Insulin Lispro Protamine and Insulin Lispro Injection (NDC 00002823305) LILLY

Monday, August 31, 2026

FDA Medroxyprogesterone Acetate Tablet (NDC 00009006501) PFIZER U.S.
FDA Medroxyprogesterone Acetate Tablet (NDC 00009005101) PFIZER U.S.
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067711) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067611) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067696) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067796) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963070911) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067811) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963070996) ACTAVIS
FDA Palovarotene Capsule (NDC 15054002501) IPSEN BIOPHARMACEUTICALS
FDA Potassium Chloride Sodium Chloride Calcium Chloride and Magn (NDC 65219025810) FRESENIUS KABI USA

Thursday, August 27, 2026

FDA Pentostatin Injection (NDC 00409080101) HOSPIRA

Tuesday, August 25, 2026

FDA Liraglutide Injection (NDC 00169280015) NOVO NORDISK
FDA Mesalamine Capsule Extended Release (NDC 00378137578) MYLAN

Monday, August 24, 2026

FDA Disopyramide Phosphate Capsule Extended Release (NDC 00025273231) PFIZER U.S.
FDA Disopyramide Phosphate Capsule Extended Release (NDC 00025274231) PFIZER U.S.

Friday, August 14, 2026

FDA Fulvestrant Injection (NDC 63323071505) FRESENIUS KABI USA

Thursday, August 13, 2026

FDA Diclofenac Sodium Tablet Delayed Release (NDC 00228255096) ACTAVIS PHARMA
FDA Diclofenac Sodium Tablet Delayed Release (NDC 00228255111) ACTAVIS PHARMA
FDA Diclofenac Sodium Tablet Delayed Release (NDC 00228255196) ACTAVIS PHARMA
FDA Diclofenac Sodium Tablet Delayed Release (NDC 00228255006) ACTAVIS PHARMA
FDA Diclofenac Sodium Tablet Delayed Release (NDC 00228255106) ACTAVIS PHARMA
FDA Diclofenac Sodium Tablet Delayed Release (NDC 00228255011) ACTAVIS PHARMA
FDA Polyethylene glycol 3350 Sodium Ascorbate Sodium Sulfate Anh (NDC 65649040001) BAUSCH HEALTH US

Monday, August 10, 2026

FDA Glyburide Tablet (NDC 00093943301) TEVA PHARMACEUTICALS USA
FDA Glyburide Tablet (NDC 00093936410) TEVA PHARMACEUTICALS USA
FDA Glyburide Tablet (NDC 00093947753) TEVA PHARMACEUTICALS USA
FDA Glyburide Tablet (NDC 00093936401) TEVA PHARMACEUTICALS USA

Monday, August 3, 2026

FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941040907) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941042952) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941041106) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941041307) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941041107) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941041306) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941042753) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941045705) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941042652) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941043051) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941042752) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941045905) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941041507) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941042451) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941042953) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941041506) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941043351) BAXTER HEALTHCARE CORP
FDA Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chlor (NDC 00941042653) BAXTER HEALTHCARE CORP

Thursday, July 30, 2026

FDA Doxycycline Hyclate Tablet Delayed Release (NDC 00591455022) TEVA PHARMACEUTICALS USA
FDA Doxycycline Hyclate Tablet Delayed Release (NDC 00591457560) TEVA PHARMACEUTICALS USA
FDA Glycopyrrolate Injection (NDC 63323057802) FRESENIUS KABI USA
FDA Glycopyrrolate Injection (NDC 63323057805) FRESENIUS KABI USA
FDA Glycopyrrolate Injection (NDC 65219080101) FRESENIUS KABI USA
FDA Glycopyrrolate Injection (NDC 63323057801) FRESENIUS KABI USA

Monday, July 27, 2026

FDA Fluticasone Propionate and Salmeterol Xinafoate Aerosol Mete (NDC 00173071522) GLAXO SMITH KLINE
FDA Fluticasone Propionate and Salmeterol Xinafoate Aerosol Mete (NDC 00173071622) GLAXO SMITH KLINE
FDA Fluticasone Propionate and Salmeterol Xinafoate Aerosol Mete (NDC 00173071722) GLAXO SMITH KLINE

Friday, July 24, 2026

FDA Lopinavir and Ritonavir Oral Solution (NDC 00074395646) ABBVIE
FDA Lopinavir and Ritonavir Tablet (NDC 00074300860) ABBVIE
FDA Lopinavir and Ritonavir Tablet (NDC 00074679922) ABBVIE
FDA Lopinavir and Ritonavir Tablet (NDC 00074401412) ABBVIE
FDA Lopinavir and Ritonavir Tablet (NDC 00074052260) ABBVIE
FDA Ritonavir Oral Powder (NDC 00074339930) ABBVIE
FDA Ritonavir Tablet (NDC 00074234030) ABBVIE

Thursday, July 23, 2026

FDA Aspirin Suppository (NDC 00574703412)
FDA Belladonna and Opium Suppository (NDC 00574704504) PADAGIS
FDA Belladonna and Opium Suppository (NDC 00574704012) PADAGIS
FDA Belladonna and Opium Suppository (NDC 00574704512) PADAGIS
FDA Belladonna and Opium Suppository (NDC 00574704004) PADAGIS
FDA Bendamustine Hydrochloride Injection Solution (NDC 63459039008) TEVA PHARMACEUTICALS USA
FDA Hydrocortisone Acetate Suppository (NDC 00574709312) PADAGIS
FDA Hydrocortisone Acetate Suppository (NDC 00574709012) PADAGIS
FDA Hydromorphone Hydrochloride Suppository (NDC 00574722406) PADAGIS
FDA Morphine Sulfate Suppository (NDC 00574711612) PADAGIS
FDA Morphine Sulfate Suppository (NDC 00574711012) PADAGIS
FDA Morphine Sulfate Suppository (NDC 00574711412) PADAGIS
FDA Morphine Sulfate Suppository (NDC 00574711212) PADAGIS
FDA Podophyllum Resin Topical Tincture (NDC 00574060115) PADAGIS
FDA Succinylcholine Chloride Injection (NDC 63323094310) FRESENIUS KABI USA

Important: Items shown in shortage are based on information provided by wholesalers when they list manufacturer out and discontinued items. Items are shown for 60 days from date of initial insertion on this list.